Talis Biomedical Corporation announced that Rob Kelley, the Company's current Chief Commercial Officer, has been promoted to Chief Executive Officer, effective immediately. Brian Blaser has stepped down from the positions of President, Chief Executive Officer and Director, due to personal matters. Mr. Kelley has more than 25 years of leadership experience in the biotechnology industry and has served as the Company’s Chief Commercial Officer since September 2020.